Assignee
MOLECURE S A
PL·5 granted patents·3 pending applications·1 citations·filing 2020–2024
Top patents by PatentIndex Score
8 records- 0172US11746107B2Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amineMOLECURE S A·Filed 2020·Granted Sep 5, 2023·1 cites·14 claims
- 0263US12319677B2Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amineMOLECURE S A·Filed 2023·Granted Jun 3, 2025·0 cites·11 claims
- 0358US2024336635A1Process for the production of (1r,2s,5r)-1-amino-5-[2-(dihydroxyboranyl)ethyl]-2-[(dimethylamino)methyl]-cyclohexane-1-carboxylic acidMOLECURE S A·Filed 2024·Application pending·0 cites
- 0456US2024150362A1Substituted PyrrolotriazinesMOLECURE S A·Filed 2023·Application pending·0 cites
- 0555US12404279B2Deubiquitinase inhibitors and methods of use thereofMOLECURE S A·Filed 2022·Granted Sep 2, 2025·0 cites·5 claims
- 0653US2023348516A1Ykl-40 inhibitors and their therapeutic applicationsMOLECURE S A·Filed 2023·Application pending·0 cites
- 0750US11638707B2Substituted amino triazoles useful as chitinase inhibitorsMOLECURE S A·Filed 2020·Granted May 2, 2023·0 cites·14 claims
- 0848US12325701B2YKL-40 inhibitors and their therapeuticMOLECURE S A·Filed 2023·Granted Jun 10, 2025·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →